Concentration of both choline plasmalogen (PC-Pls) and ethanolamine Pls (PE-Pls) in
human plasma/serum has been getting attention to, since certain patients including those …

Plasmalogens (Pls) levels are reported to be altered in several neurological and metabolic
diseases. Identification of sn-1 fatty alcohols and sn-2 fatty acids of different Pls species is …

Tandem mass spectrometry (MS/MS) has been used for the analysis of plasmalogen (Pls), a
physiologically important class of vinyl ether-linked phospholipid. However, MS/MS …

Background Serum plasmalogens (Pls) have gained interest in several clinical symptoms
such as metabolic syndrome/atherosclerosis or Alzheimer's disease possibly because of …

Plasmalogens are alkenyl-acyl glycerophospholipids and decreased in post-mortem
Alzheimer's disease (AD) brains. The aim of this study is to investigate the time-dependent …

Plasmalogens (Pls) are one kind of phospholipids enriched in the brain and other organs.
These lipids were thought to be involved in the membrane bilayer formation and anti-oxidant …

Ether phospholipid compositions are altered in the plasma or brain of patients with brain
disorders, such as Alzheimer and Parkinson's disease, including those with psychiatric …

To explore the hypothesis that alterations in ethanolamine plasmalogen may be directly
related to the severity of dementia in Alzheimer's disease (AD), we performed a systematic …

It has been reported in recent years that blood levels of plasmalogens (Pls) are decreased in
various diseases. None of those reports, however, conducted any clinical trials to examine …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by
extracellular senile plaques mainly consisting of Aβ, a 40–42 amino acid long peptide, and …